Sunko Ink Past Earnings Performance
Past criteria checks 0/6
Sunko Ink's earnings have been declining at an average annual rate of -35.8%, while the Chemicals industry saw earnings growing at 6.2% annually. Revenues have been declining at an average rate of 6.4% per year.
Key information
-35.8%
Earnings growth rate
-35.7%
EPS growth rate
| Chemicals Industry Growth | 7.9% |
| Revenue growth rate | -6.4% |
| Return on equity | -13.2% |
| Net Margin | -12.7% |
| Next Earnings Update | 07 May 2024 |
Recent past performance updates
Recent updates
Would Sunko Ink (TWSE:1721) Be Better Off With Less Debt?
Feb 27
Is It Worth Buying Sunko Ink Co., Ltd. (TPE:1721) For Its 4.6% Dividend Yield?
Mar 30Sunko Ink (TPE:1721) Has Debt But No Earnings; Should You Worry?
Feb 22A Look At Sunko Ink's (TPE:1721) Share Price Returns
Jan 17Should You Rely On Sunko Ink's (TPE:1721) Earnings Growth?
Dec 13
Revenue & Expenses BreakdownBeta
How Sunko Ink makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 2,186 | -278 | 150 | 47 |
| 30 Sep 23 | 2,302 | -236 | 142 | 48 |
| 30 Jun 23 | 2,432 | -152 | 151 | 49 |
| 31 Mar 23 | 2,787 | -19 | 166 | 50 |
| 31 Dec 22 | 3,009 | 61 | 173 | 50 |
| 30 Sep 22 | 3,141 | 124 | 190 | 51 |
| 30 Jun 22 | 3,089 | 33 | 180 | 50 |
| 31 Mar 22 | 2,921 | -4 | 172 | 51 |
| 31 Dec 21 | 2,851 | -70 | 173 | 51 |
| 30 Sep 21 | 2,646 | -161 | 165 | 51 |
| 30 Jun 21 | 2,667 | -98 | 171 | 51 |
| 31 Mar 21 | 2,649 | 496 | 305 | 53 |
| 31 Dec 20 | 2,753 | 524 | 329 | 54 |
| 30 Sep 20 | 2,921 | 568 | 345 | 56 |
| 30 Jun 20 | 3,116 | 575 | 350 | 57 |
| 31 Mar 20 | 3,214 | -43 | 225 | 57 |
| 31 Dec 19 | 3,244 | -7 | 208 | 56 |
| 30 Sep 19 | 3,295 | 11 | 214 | 56 |
| 30 Jun 19 | 3,357 | 31 | 223 | 56 |
| 31 Mar 19 | 3,490 | 53 | 226 | 56 |
| 31 Dec 18 | 3,452 | 16 | 230 | 57 |
| 30 Sep 18 | 3,497 | 34 | 229 | 58 |
| 30 Jun 18 | 3,500 | 70 | 220 | 57 |
| 31 Mar 18 | 3,342 | 46 | 220 | 55 |
| 31 Dec 17 | 3,409 | 70 | 223 | 49 |
| 30 Sep 17 | 3,335 | 126 | 235 | 46 |
| 30 Jun 17 | 3,271 | 103 | 236 | 44 |
| 31 Mar 17 | 3,423 | 185 | 279 | 47 |
| 31 Dec 16 | 3,579 | 231 | 292 | 54 |
| 30 Sep 16 | 3,759 | 169 | 309 | 59 |
| 30 Jun 16 | 3,926 | 181 | 354 | 60 |
| 31 Mar 16 | 4,080 | 128 | 354 | 58 |
| 31 Dec 15 | 4,064 | 95 | 361 | 55 |
| 30 Sep 15 | 3,453 | 77 | 316 | 42 |
| 30 Jun 15 | 2,841 | 41 | 247 | 31 |
| 31 Mar 15 | 2,163 | 23 | 190 | 26 |
| 31 Dec 14 | 1,578 | 8 | 148 | 16 |
| 30 Sep 14 | 1,602 | -3 | 177 | 16 |
| 30 Jun 14 | 1,663 | 7 | 175 | 15 |
| 31 Mar 14 | 1,751 | 9 | 172 | 15 |
| 31 Dec 13 | 1,709 | 5 | 168 | 19 |
| 30 Sep 13 | 1,708 | 8 | 121 | 21 |
| 30 Jun 13 | 1,690 | 2 | 115 | 26 |
Quality Earnings: 1721 is currently unprofitable.
Growing Profit Margin: 1721 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1721 is unprofitable, and losses have increased over the past 5 years at a rate of 35.8% per year.
Accelerating Growth: Unable to compare 1721's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 1721 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-20.9%).
Return on Equity
High ROE: 1721 has a negative Return on Equity (-13.19%), as it is currently unprofitable.